Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541359
PUBLISHER: IMARC | PRODUCT CODE: 1541359
Lymphoma Treatment Market Report by Type, Test Type, Drug, and Region 2024-2032
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global lymphoma treatment market size reached US$ 13.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Lymphoma refers to a type of cancer characterized by the rapid development of abnormal malignant cells in the lymphatic system. It usually targets the white blood cells (WBCs), or lymphocytes, in lymph nodes, spleen, thymus and bone marrow and impairs the immune response of the body. As a result, the patient develops swelling in the lymph nodes, high fever, weight loss, dyspnea and fatigue. Some of the commonly used lymphoma therapeutics include radiation, chemo and monoclonal antibody therapy, active surveillance, bone marrow transplant and immunotherapy drugs. These therapeutics are widely used for the treatment of both Hodgkin and non-Hodgkin lymphoma.
The increasing prevalence of non-Hodgkin lymphoma across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. In line with this, the increasing awareness among the masses regarding the available diagnostic technologies and treatment alternatives for lymphoma is also creating a positive outlook for the market. Hospitals and other diagnostic centers are using innovative tests and imaging technologies, such as computed tomography (CT), Magnetic Resonance Imaging (MRI) and positron emission tomography (PET) scans, for accurate identification of the cancer cells and timely treatment. Additionally, various technological advancements, including the development of innovative immune checkpoint inhibitors, which block proteins from binding together and increase the response strength of T-cells against cancer cells, are contributing to the market growth. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with overall improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lymphoma treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, test type and drug.
Breakup by Type:
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Breakup by Test Type:
Chemotherapy
Radiation Therapy
Immunotherapy
Targeted Therapy
Biologic Therapy
Others
Breakup by Drug:
Adcetris
Rituxan
Opdivo
Imbruvica
Keytruda
Revlimid
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
- How has the global lymphoma treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global lymphoma treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the drug?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global lymphoma treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A3385
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Lymphoma Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Hodgkin Lymphoma
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Non-Hodgkin Lymphoma
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Test Type
- 7.1 Chemotherapy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Radiation Therapy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Immunotherapy
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Targeted Therapy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Biologic Therapy
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Drug
- 8.1 Adcetris
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Rituxan
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Opdivo
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Imbruvica
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Keytruda
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Revlimid
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bristol-Myers Squibb Company
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Eli Lilly and Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche Ltd.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Johnson & Johnson Services, Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Merck & Co. Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Novartis International AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Spectrum Pharmaceuticals, Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Takeda Pharmaceutical Company Ltd.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Teva Pharmaceutical Industries Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112024A3385
List of Figures
- Figure 1: Global: Lymphoma Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Lymphoma Treatment Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Lymphoma Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Lymphoma Treatment Market: Breakup by Type (in %), 2023
- Figure 5: Global: Lymphoma Treatment Market: Breakup by Test Type (in %), 2023
- Figure 6: Global: Lymphoma Treatment Market: Breakup by Drug (in %), 2023
- Figure 7: Global: Lymphoma Treatment Market: Breakup by Region (in %), 2023
- Figure 8: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Lymphoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Lymphoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Lymphoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Lymphoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Lymphoma Treatment (Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Lymphoma Treatment (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Lymphoma Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Lymphoma Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Lymphoma Treatment (Biologic Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Lymphoma Treatment (Biologic Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Lymphoma Treatment (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Lymphoma Treatment (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Lymphoma Treatment (Adcetris) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Lymphoma Treatment (Adcetris) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Lymphoma Treatment (Rituxan) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Lymphoma Treatment (Rituxan) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Lymphoma Treatment (Opdivo) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Lymphoma Treatment (Opdivo) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Lymphoma Treatment (Imbruvica) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Lymphoma Treatment (Imbruvica) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Lymphoma Treatment (Keytruda) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Lymphoma Treatment (Keytruda) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Lymphoma Treatment (Revlimid) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Lymphoma Treatment (Revlimid) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Lymphoma Treatment (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Lymphoma Treatment (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: North America: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: North America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: United States: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: United States: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Canada: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Canada: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Asia-Pacific: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Asia-Pacific: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: China: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: China: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Japan: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Japan: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: India: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: India: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: South Korea: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: South Korea: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Australia: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Australia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Indonesia: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Indonesia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Europe: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Europe: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Germany: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Germany: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: France: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: France: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: United Kingdom: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: United Kingdom: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Italy: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Italy: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Spain: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Spain: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Russia: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Russia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Latin America: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Latin America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Brazil: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Brazil: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Mexico: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Mexico: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Middle East and Africa: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Middle East and Africa: Lymphoma Treatment Market: Breakup by Country (in %), 2023
- Figure 86: Middle East and Africa: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Global: Lymphoma Treatment Industry: SWOT Analysis
- Figure 88: Global: Lymphoma Treatment Industry: Value Chain Analysis
- Figure 89: Global: Lymphoma Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Lymphoma Treatment Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Lymphoma Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Lymphoma Treatment Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
- Table 4: Global: Lymphoma Treatment Market Forecast: Breakup by Drug (in Million US$), 2024-2032
- Table 5: Global: Lymphoma Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Lymphoma Treatment Market: Competitive Structure
- Table 7: Global: Lymphoma Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.